Seres Therapeutics
MCRB
#8989
Rank
NZ$0.22 B
Marketcap
NZ$24.64
Share price
-3.64%
Change (1 day)
-16.56%
Change (1 year)

Market capitalization of Seres Therapeutics (MCRB)

Market cap: NZ$0.22 Billion

As of February 2026 Seres Therapeutics has a market cap of NZ$0.22 Billion. This makes Seres Therapeutics the world's 8989th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Seres Therapeutics from 2015 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.22 B-2.57%
2025NZ$0.22 B-10.23%
2024NZ$0.25 B-10.91%
2023NZ$0.28 B-73.96%
2022NZ$1.09 B-1.94%
2021NZ$1.12 B-63.91%
2020NZ$3.10 B764.27%
2019NZ$0.35 B30.26%
2018NZ$0.27 B-52.33%
2017NZ$0.57 B0.33%
2016NZ$0.57 B-71.22%
2015NZ$2.00 B

End of Day market cap according to different sources

On Feb 3rd, 2026 the market cap of Seres Therapeutics was reported to be:

NZ$0.23 Billion
by Nasdaq info icon info icon
NZ$0.23 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Xencor
XNCR
NZ$1.40 B 529.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Agios Pharmaceuticals
AGIO
NZ$2.71 B 1,116.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$18.15 B 8,042.70%๐Ÿ‡บ๐Ÿ‡ธ USA